| Study | Cancer Type | Enhancer RNAs | Sample | Binding factors | Transcriptional orientation | Epigenetic characteristics |
| Li et al. (2013) | BC | TFF1, FOXC1, CA12, PGR SIAH2, KCNK5, P2RY2 SMAD7, GREB1, NRIP1 | MCF-7 | RNAPII, ERα | 1D and 2D | High H3K4me1, low H3K4me3 and high H3K27Ac | Leveille et al. (2015) | BC | P21, TOB1, PRKAG2, SUFU | MCF-7 | RNAPII, p300, p53 | 1D and 2D | High H3K4me1, low H3K4me3 | Zhao et al. (2016) | CRPC | ARHGEF26, KLK15, HTR3A TLE1, SLC16A7 | LNCaP, C4-2 | RNAPII, p300, AR | 2D | High H3K4me1, low H3K4me3 | Zhao et al. (2016) | CRPC | FTO, LUZP2, MARC1 NCAM2 | LNCaP, C4-2 | RNAPII, p300, AR | 2D | High H3K4me1, low H3K4me3 | McCleland et al. (2016) | CRC | CCAT1 | HT-29 | RNAPII | 2D | High H3K4me1, low H3K4me3 | Bal et al. (2017) | BCC | ACTRT1 | Keratinocyte | RNAPII | 1D and 2D | High H3K4me1, low H3K4me3 and high H3K27Ac |
|
|